Dermata Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Dermata Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $7.52 million for the year ending 2025.

  • Dermata Therapeutics, Inc. showed an increase of +137.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Dermata Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2025), Dermata Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,318.2%.
  • Historical annual values: Fiscal year 2025: $7.52 million | Fiscal year 2024: $3.16 million | Fiscal year 2022: $6.24 million | Fiscal year 2021: $10.80 million | Fiscal year 2020: $530.4 thousand.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: